Histological Transformation | List of Frontiers open access articles

Mini Review

Published on 30 Oct 2023

Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy

in Cancer Immunity and Immunotherapy

Jiao Zeng
Xinjing Ding
Jianghua Ding
Xin Wang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1275957

10,090 views
21 citations

Case Report

Published on 24 Oct 2024

Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report

in Cancer Immunity and Immunotherapy

Jieying Li
Xiaohong Zhan
Wei Shang
Kai Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1484915

1,878 views

Case Report

Published on 10 Jan 2022

Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma

in Molecular and Cellular Oncology

Lingling Zhu
Yanyang Liu
Honglin Gao
Jiewei Liu
Qinghua Zhou
Feng Luo

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2021.755135

4,258 views
4 citations

Case Report

Published on 25 Sep 2024

Case report: Emerging therapies for transformed small cell lung cancer: efficacy of serplulimab and a comprehensive case report

in Pulmonary Medicine

Heng-Xu Lyu
Wen-Hua Ma
Yong-Qian Zhang
Hui Jin
Yu-Dong Wang
Min Zhao

Frontiers in Medicine

doi 10.3389/fmed.2024.1406515

2,733 views
3 citations

Case Report

Published on 08 Jun 2021

Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment

in Molecular and Cellular Oncology

Jiatao Liao
Yuan Li
Chang Liu
Qianqian Long
Jialei Wang

Frontiers in Oncology

doi 10.3389/fonc.2021.696881

4,142 views
5 citations

Case Report

Published on 09 Nov 2022

Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases

in Cancer Immunity and Immunotherapy

Hao Liu
Li-Hong Chen
Zhi-Hui Zhang
Ning Wang
Si-Hui Zhuang
Hao Chen
Jin Du
Li-Juan Pang
Yan Qi

Frontiers in Oncology

doi 10.3389/fonc.2022.1022705

4,586 views
17 citations

Case Report

Published on 07 Dec 2022

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

in Thoracic Oncology

Meng-Hang Yang
Jia Yu
Chen-Lei Cai
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.1029282

4,729 views
12 citations

Case Report

Published on 23 Apr 2024

ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report

in Thoracic Oncology

Rui Chen
Yan Jian
Yuzhen Liu
Junping Xie

Frontiers in Oncology

doi 10.3389/fonc.2024.1395654

3,120 views
3 citations

Case Report

Published on 26 May 2022

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

in Thoracic Oncology

Junru Ye
Yutong Ma
Qiuxiang Ou
Junrong Yan
Bin Ye
Yuping Li

Frontiers in Oncology

doi 10.3389/fonc.2022.883367

4,540 views
6 citations

Systematic Review

Published on 23 Nov 2023

Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials

in Cancer Immunity and Immunotherapy

Mário Sousa-Pimenta
Ângelo Martins
José Mário Mariz
Pedro Berraondo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1295293

6,096 views
5 citations

Original Research

Published on 16 Jun 2022

Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis

in Hematologic Malignancies

Tevfik Hatipoğlu
Esra Esmeray Sönmez
Xiaozhou Hu
Hongling Yuan
Ayça Erşen Danyeli
Ahmet Şeyhanlı
Tuğba Önal-Süzek
Weiwei Zhang
Burcu Akman
Aybüke Olgun

Frontiers in Oncology

doi 10.3389/fonc.2022.870487

10,611 views
14 citations

Original Research

Published on 06 May 2021

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

in Thoracic Oncology

Maria Gabriela O. Fernandes
Catarina Sousa
Maria Jacob
Leonor Almeida
Vanessa Santos
David Araújo
Hélder Novais Bastos
Adriana Magalhães
Luís Cirnes
Conceição Souto Moura

Frontiers in Oncology

doi 10.3389/fonc.2021.602924

5,865 views
8 citations

Original Research

Published on 16 Sep 2022

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China

in Hematologic Malignancies

Fenghua Gao
Tingting Zhang
Xia Liu
Zhenjie Qu
Xianming Liu
Lanfang Li
Lihua Qiu
Zhengzi Qian
Shiyong Zhou
Wenchen Gong

Frontiers in Oncology

doi 10.3389/fonc.2022.863021

7,503 views
7 citations

Articles

Histological transformation into SCLC: An important resistance mechanism of NSCLC upon immunotherapy

Sarcomatoid carcinoma transformation in oral undifferentiated carcinoma following sequential immune combined targeted therapy: a case report

Case Report: Partial Response Following Nivolumab Plus Docetaxel in a Patient With EGFR Exon 20 Deletion/Insertion (p.N771delinsGF) Mutant Lung Adenocarcinoma Transdifferentiated From Squamous Cell Carcinoma

Case report: Emerging therapies for transformed small cell lung cancer: efficacy of serplulimab and a comprehensive case report

Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment

Histomorphological transformation from non-small cell lung carcinoma to small cell lung carcinoma after targeted therapy or immunotherapy: A report of two cases

Small cell lung cancer transformation and tumor heterogeneity after sequential targeted therapy and immunotherapy in EGFR-mutant non-small cell lung cancer: A case report

ALK-rearranged and EGFR wild-type lung adenocarcinoma transformed to small cell lung cancer: a case report

Long-Term Clinical Benefit in EGFR-Mutant Lung Adenocarcinoma With Local Squamous Cell Carcinoma Transformation After EGFR TKI Resistance: A Case Report

Response to therapy in Richter syndrome: a systematic review with meta-analysis of early clinical trials

Plasma Concentrations and Cancer-Associated Mutations in Cell-Free Circulating DNA of Treatment-Naive Follicular Lymphoma for Improved Non-Invasive Diagnosis and Prognosis

Resistance Profile of Osimertinib in Pre-treated Patients With EGFR T790M-Mutated Non-small Cell Lung Cancer

Clinical features and outcomes of patients with follicular lymphoma: A real-world study of 926 patients in China